Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.39 USD | -0.37% | +4.95% | +31.19% |
May. 13 | Oppenheimer Adjusts Achieve Life Sciences Price Target to $11 From $18, Maintains Outperform Rating | MT |
May. 09 | Transcript : Achieve Life Sciences, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.19% | 186M | |
+50.80% | 63.85B | |
-2.64% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.73% | 26.52B | |
-21.20% | 18.69B | |
+2.97% | 12.73B | |
+22.27% | 12.11B | |
+27.79% | 12.07B |
- Stock Market
- Equities
- ACHV Stock
- News Achieve Life Sciences, Inc.
- Oppenheimer Adjusts Achieve Life Sciences Price Target to $11 From $18, Maintains Outperform Rating